| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000238113.2 |
Ponatinib |
Brain lower grade glioma |
0.006213753 |
Resistant |
| ENSG00000238113.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.012649938 |
Resistant |
| ENSG00000238113.2 |
Ponatinib |
Esophageal cancer |
0.016768543 |
Sensitive |
| ENSG00000238113.2 |
Ponatinib |
Thyroid carcinoma |
0.047163449 |
Sensitive |
